ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs MXN
18.4648
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,188.13
-0.01%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. USOTC
  6. VIA Pharmaceuticals Inc (CE) (VIAP)

  7. VIA Pharmaceuticals Inc (CE) (VIAP) Noticias

VIAP

VIA Pharmaceuticals (CE) (VIAP)

VIA Pharmaceuticals Inc (CE)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:USOTC:VIAP
FechaHoraFuenteTítuloSímboloCompañía
13/06/201107:00MarketwiredVIA Pharmaceuticals Announces First-in-Human Dosing of VIA-3196 for Treatment of DyslipidemiaUSOTC:VIAPVIA Pharmaceuticals Inc (CE)
25/03/201116:03Edgar (US Regulatory)Termination of Registration of a Class of Security under Section 12(g) (15-12G)USOTC:VIAPVIA Pharmaceuticals Inc (CE)
24/03/201114:58Edgar (US Regulatory)Annual Report (10-K)USOTC:VIAPVIA Pharmaceuticals Inc (CE)
11/02/201113:55Edgar (US Regulatory)Statement of Ownership (SC 13G)USOTC:VIAPVIA Pharmaceuticals Inc (CE)
18/01/201116:09Edgar (US Regulatory)Current report filing (8-K)USOTC:VIAPVIA Pharmaceuticals Inc (CE)
03/01/201105:01Edgar (US Regulatory)Notice of Effectiveness (EFFECT)USOTC:VIAPVIA Pharmaceuticals Inc (CE)
30/12/201012:14Edgar (US Regulatory)Post-Effective Amendment to Registration Statement (POS AM)USOTC:VIAPVIA Pharmaceuticals Inc (CE)
30/12/201012:06Edgar (US Regulatory)Post-Effective Amendment to an S-8 filing (S-8 POS)USOTC:VIAPVIA Pharmaceuticals Inc (CE)
17/11/201015:47Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)USOTC:VIAPVIA Pharmaceuticals Inc (CE)
17/11/201014:41Edgar (US Regulatory)Amended Small Company Offering and Sale of Securities Without Registration (D/A)USOTC:VIAPVIA Pharmaceuticals Inc (CE)
17/11/201014:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:VIAPVIA Pharmaceuticals Inc (CE)
15/11/201015:30Edgar (US Regulatory)Quarterly Report (10-Q)USOTC:VIAPVIA Pharmaceuticals Inc (CE)
20/05/201006:30MarketwiredVIA Pharmaceuticals and MHI Announce Publication of VIA-2291 5-Lipoxygenase Inhibitor Clinical Study Data in Circulation: CardioUSOTC:VIAPVIA Pharmaceuticals Inc (CE)
30/04/201016:05Edgar (US Regulatory)Amended Annual Report (10-K/A)USOTC:VIAPVIA Pharmaceuticals Inc (CE)
31/03/201015:01MarketwiredVIA Pharmaceuticals Announces Strategic Restructuring and FinancingUSOTC:VIAPVIA Pharmaceuticals Inc (CE)
26/02/201008:45Edgar (US Regulatory)(25-NSE)USOTC:VIAPVIA Pharmaceuticals Inc (CE)
16/02/201012:28Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)USOTC:VIAPVIA Pharmaceuticals Inc (CE)
 Showing the most relevant articles for your search:USOTC:VIAP

Su Consulta Reciente

NYSE
KO
Coca Cola
NYSE
VZ
Verizon Communications
NASDAQ
AMZN
Amazon.com
NASDAQ
AAPL
Apple
NYSE
MRK
Merck
NYSE
BAC
Bank of America
COIN
BTCUSD
Bitcoin
USI
USTECH100
US Tech 100
COIN
ETHUSD
Ethereum
FX
EURMXN
Euro vs MXN
NYSE
MCD
McDonalds
AMEX
XLF
Financial Select Sector
USOTC
RHHBY
Roche (QX)
NASDAQ
MSFT
Microsoft
AMEX
SPY
SPDR S&P 500
USOTC
DTEGY
Deutsche Telekom (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados